Health ministry approves new tuberculosis drug
The technical group on tuberculosis in the health ministry has given approval to Delamanid, which is in its phase 3 clinical trials
New Delhi: Perturbed by the increasing number of multi-drug resistant (MDR) and extensive drug resistant (XDR) tuberculosis cases in India, the health ministry has approved the use of a new drug in the treatment of such cases.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more